Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135258) titled 'Atrial Fibrillation: In Search for the Optimal Target for Rate Control' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: The University of Hong Kong
Condition:
Atrial Fibrillation (Permanent)
Atrial Fibrillation (AF)
Intervention:
Drug: Ivabradine + Usual Care
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 1, 2025
Target Sample Size: 200
Countries of Recruitment:
Hong Kong
To know more, vis...